G - Physics – 01 – N
Patent
G - Physics
01
N
G01N 33/68 (2006.01)
Patent
CA 2380489
The invention relates to a novel selective modulating binding site on the potassium channel with the subunits KCNQ2 and KCNQ3 that are characterized by retigabine. This novel binding site can be used to screen and find novel substances for treating diseases that are related to a hyperexcitability or a hypoexcitability of the neuronal cells.
L'invention concerne un nouveau site de fixation de modulation sélective du canal de potassium comprenant les sous-unités KCNQ2 et KCNQ3 et caractérisée par le rétigabine. Ce site permet d'analyser et de détecter de nouveaux principes actifs en vue de traiter les maladies dues à une surexcitation ou à une excitabilité insuffisante des cellules neuronales.
Netzer Rainer
Rundfeldt Chris
Arzneimittelwerk Dresden Gmbh
Elbion Ag
Ogilvy Renault Llp/s.e.n.c.r.l.,s.r.l.
LandOfFree
Modulating binding site on potassium channels used for... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Modulating binding site on potassium channels used for..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Modulating binding site on potassium channels used for... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1500755